Bloomington Leader

Researchers at Indiana University Bloomington have conducted a study examining the sting of the Scarlet Velvet Ant, revealing its potential implications for pain-related medical research. The insect's venomous sting is known for being intensely painful but not particularly toxic, suggesting it serves primarily as a deterrent against predators. This insight into the evolutionary strategies of velvet ants could inform future studies on pain management.

The study was published in Current Biology and involved several authors from IU, including Lydia Borjon, Luana Assis Ferreira, Jonathan Trinidad, Andrea Hohmann, Sunčica Šašić, and Dan Tracey. The researchers focused on how the venom interacts with nociceptors—nerve cells responsible for sensing pain—using fruit fly larvae as model organisms.

The team identified a peptide called Do6a in the venom that activates these pain-sensing ion channels in insects. Interestingly, these channels are similar to Acid-Sensing Ion Channels (ASICs) found in vertebrates like mammals and humans. "Our study findings suggest that velvet ants target the pain-sensing systems of evolutionarily distant animals," said Borjon.

In experiments involving praying mantises and mice, the venom showed species-specific adaptations. While potent in insects like fruit flies and effective as a deterrent for mantises, Do6a did not significantly affect mice. However, other components of the venom triggered pain responses in vertebrates.

"Exploring how velvet ant venom affects different species provides valuable insights into pain pathways," stated Ferreira. These findings may aid future developments in painkillers or treatments for chronic pain by targeting similar pathways in humans.

Andrea Hohmann emphasized that venoms offer numerous bioactive compounds beneficial to pharmacology and medicine. Meanwhile, Tracey highlighted the precision of evolutionary adaptations seen in velvet ants' defense mechanisms: "This research offers a deeper appreciation of nature’s complexity."

###